Download free PDF

Digital Diabetes Management Market Size & Share 2023 to 2032

Market Size by Product Type (Devices, Services), by Patient Type (Type 1, Type 2), by End Use (Hospitals, Home Settings.

Report ID: GMI4903
   |
Published Date: June 2023
 | 
Report Format: PDF

Download Free PDF

Digital Diabetes Management Market Size

Digital Diabetes Management Market size was worth USD 18.9 billion in 2022. Driven by the rising prevalence of diabetes globally, the industry could grow at 20% CAGR from 2023 to 2032.

Digital Diabetes Management Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 18.9 Billion
  • 2032 Forecast Market Size: USD 117.8 Billion
  • CAGR (2023–2032): 20.0%

Key Market Drivers

  • Rising number of people suffering from diabetes.
  • Advent of artificial intelligence and big data analytics in diabetes devices.
  • Rising healthcare expenditure towards diabetes.
  • Growing awareness about technologically advanced products.
  • Favorable reimbursement policies.

Challenges

  • Rising number of product launches.
  • High cost of advanced devices.

 

Growing adoption of a sedentary lifestyle, poor eating habits, and rising cases of obesity have increased the occurrence of diabetes, increasing the demand for digital diabetes management for remote patient monitoring. As per the International Diabetes Federation, in 2021, the global diabetes prevalence in people aged between 20 to 79 years was 10.5% (536.6 million people), which is projected to reach around 783 million people by 2045.

 

COVID-19 Impact

The COVID-19 pandemic asserted a profound impact on the digital diabetes management market. The high susceptibility of diabetes patients to COVID1-9 infection increased the demand for remote patient monitoring devices for continued disease monitoring. Many government authorities across the globe also granted emergency use authorization for diabetes care devices. For instance, the U.S. FDA rolled out the guidance for permitting home-based blood glucose meters in hospitals. Such initiatives further helped strengthen the market outlook during the crisis.

 

Digital Diabetes Management Market

Digital Diabetes Management Market Trends

The advent of big data analytics and AI in diabetes devices will create ample opportunities for the market. AI technology has gained immense traction in insulin monitoring, insulin injection guidance, diabetes prediction, and exercise guidance in diabetes management. Moreover, a remarkable growth in AI technology is helping healthcare providers get access to large data sets of diabetes patients. This high availability of information is helping patients get customized treatment for enhanced clinical outcomes thus, stimulating industry revenue streams.

 

Digital Diabetes Management Market Analysis

Digital Diabetes Management Market, By Product Type, 2021-2032 (USD Billion)

Based on product, Digital diabetes management market share from the services segment will grow at over 18.5% CAGR from 2023 to 2032. Rapid advancements in diabetes management apps and software will present new pathways for segment growth. Some diabetes management apps can now integrate fitness trackers and wearable medical devices, such as smartwatches and activity monitors. This integration allows individuals to track their physical activity levels, monitor their heart rate, and estimate the impact of exercise on their blood sugar levels.
 

Digital Diabetes Management Market Share, By End-use, 2022

With respect to end-use, the digital diabetes management market size from the hospitals segment reached over USD 7 billion in 2022. Growing usage of digital technologies for remote patient monitoring in hospitals will contribute to segment growth. Moreover, the high availability of advanced digital diabetes management tools, such as insulin delivery devices, has increased patient visits to these facilities. Many governments across the globe also granted approval for a few digital diabetes management products in hospitals during COVID-19, thereby augmenting segment gains.
 

U.S. Digital Diabetes Management Market Size, 2020-2032 (USD Billion)

On the regional front, North America digital diabetes management market will grow at over 19% CAGR between 2023 and 2032. Growing prevalence of diabetes has increased the need for diabetes care devices in the region. Supportive government initiatives for the treatment of the disease are creating a favorable growth outlook for the regional industry. In fact, in November 2021, the government of Canada and partners announced an investment of USD 20 million in new diabetes research teams for the treatment of people living with diabetes.
 

Digital Diabetes Management Market Share

  • Ypsomed Holding
  • Tidepool
  • DarioHealth Corporation
  • Pendiq
  • Ascensia Diabetes Care Holdings Ag
  • Glooko Inc
  •  Novo Nordisk A/S
     

Digital Diabetes Management Industry News:

  • In May 2023, Medtronic plc, a global leader in healthcare technology, announced definitive agreements for the acquisition of EOFlow Co. Ltd., manufacturer of wearable insulin patches to offer the benefits of automated insulin delivery and simplify diabetes treatment. This acquisition will help strengthen the company’s industry position while broadening its product portfolio.
     
  • In April 2023, Glooko, Inc., a prominent software company, inked a Global partnership deal with Hedia, an insulin dosing algorithm company, to offer an interoperable solution that integrates remote patient monitoring, connected care, and digital therapeutic technologies to increase access to people with Type 1 and Type 2 diabetes in need of bolus insulin dosing advice.
     

The digital diabetes management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Market Size, By Product

  • Devices
    • By device
      • Smart blood glucose meters
      • Smart CGM
      • Smart insulin pumps & patches
      • Smart insulin pens
    • By device type
      • Handheld
      • Wearable
  • Services
    • Software
    • Apps

Market Size, By Patient

  • Type 1
  • Type 2

Market Size, By End-use

  • Hospital
  • Home settings
  • Diagnostic centers & clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors:  Mariam Faizullabhoy, Pratiksha Kamthe

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the digital diabetes management market worth?
In 2022, the digital diabetes management industry was valued at USD 18.9 billion and will grow at 20% CAGR from 2023 to 2032, attributed to the growing prevalence of diabetes globally.
What is encouraging the adoption of digital diabetes management services?
The market share from the services segment will grow at more than 18.5% CAGR from 2023 to 2032, owing to rapid advancements in diabetes management software and apps.
What factors will contribute to the growth of the digital diabetes management industry in North America?
North America digital diabetes management market size reached over USD 6 billion in 2022, attributed to the favorable government initiatives for diabetes treatment.
Which are the prominent companies in the digital diabetes management industry?
Major digital diabetes management industry players include Abbott Laboratories, F.Hoffmann-La Roche Ltd, Senseonics, Tandem Diabetes Care, Inc, Medtronic Plc, Dexcom, Inc, and Insulet Corporation, among others.
Digital Diabetes Management Market Scope
  • Digital Diabetes Management Market Size

  • Digital Diabetes Management Market Trends

  • Digital Diabetes Management Market Analysis

  • Digital Diabetes Management Market Share

Authors:  Mariam Faizullabhoy, Pratiksha Kamthe
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 15

Tables & Figures: 366

Countries Covered: 19

Pages: 260

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)